Investors Snag ACRS 37.3% Cheaper Than Its Secondary Stock Offering

Looking back to 113 days ago, Aclaris Therapeutics Inc (ACRS) priced a 8,645,000 share secondary stock offering at $10.75 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..